Literature DB >> 1972540

Transcriptional and posttranscriptional regulation of the proliferating cell nuclear antigen gene.

C D Chang1, L Ottavio, S Travali, K E Lipson, R Baserga.   

Abstract

The steady-state mRNA levels of the proliferating cell nuclear antigen (PCNA) gene are growth regulated. In a previous paper (L. Ottavio, C.-D. Chang, M. G. Rizzo, S. Travali, C. Casadevall, and R. Baserga, Mol. Cell. Biol. 10:303-309, 1990), we reported that introns (especially intron 4) participate in growth regulation of the PCNA gene. We have now investigated the role of the 5'-flanking sequence of the human PCNA gene stably transfected into BALB/c 3T3 cells. Promoters of different lengths (from -2856 to -45 upstream of the cap site) were tested. All promoters except the AatII promoter (-45), including a short HpaII promoter (-210), were sufficient for a response to serum, platelet-derived growth factor, and to a lesser extent epidermal growth factor. No construct responded to insulin or platelet-poor plasma. The AatII promoter had little detectable activity. Transcriptional activity was also determined in BALB/c 3T3 cells carrying various constructs of the human PCNA gene by two methods: run-on transcription and reverse transcription-polymerase chain reaction (the latter measuring the heterogeneous nuclear RNA [hnRNA] steady-state levels). There was very little difference in the rate of transcription of the PCNA gene between G0 cells and serum-stimulated cells, although the levels of hnRNA were much higher after stimulation. In G0 cells carrying a human PCNA gene without introns 4 and 5, both transcription rate and hnRNA levels were high. Together with data on the mRNA half-life, these results suggest a posttranscriptional component in the regulation of PCNA mRNA levels after serum stimulation but a transcriptional regulation by intron 4.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972540      PMCID: PMC360744          DOI: 10.1128/mcb.10.7.3289-3296.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Expression of the H-ras proto-oncogene is controlled by alternative splicing.

Authors:  J B Cohen; S D Broz; A D Levinson
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

2.  Cyclin mRNA and protein expression in recombinant interleukin 2-stimulated cloned murine T lymphocytes.

Authors:  P M Shipman; D E Sabath; A H Fischer; P G Comber; K Sullivan; E M Tan; M B Prystowsky
Journal:  J Cell Biochem       Date:  1988-11       Impact factor: 4.429

3.  Novel method for studying mRNA phenotypes in single or small numbers of cells.

Authors:  D A Rappolee; A Wang; D Mark; Z Werb
Journal:  J Cell Biochem       Date:  1989-01       Impact factor: 4.429

4.  S-phase-specific regulation by deletion mutants of the human thymidine kinase promoter.

Authors:  K E Lipson; S T Chen; J Koniecki; D H Ku; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  Primase p49 mRNA expression is serum stimulated but does not vary with the cell cycle.

Authors:  B Y Tseng; C E Prussak; M T Almazan
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

6.  A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene.

Authors:  J B Cohen; A D Levinson
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

7.  Requirement for proliferating cell nuclear antigen expression during stages of the Chinese hamster ovary cell cycle.

Authors:  Y C Liu; R L Marraccino; P C Keng; R A Bambara; E M Lord; W G Chou; S B Zain
Journal:  Biochemistry       Date:  1989-04-04       Impact factor: 3.162

8.  Structure of the human gene for the proliferating cell nuclear antigen.

Authors:  S Travali; D H Ku; M G Rizzo; L Ottavio; R Baserga; B Calabretta
Journal:  J Biol Chem       Date:  1989-05-05       Impact factor: 5.157

9.  Regulation of proliferating cell nuclear antigen during the cell cycle.

Authors:  G F Morris; M B Mathews
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

10.  Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin.

Authors:  D Jaskulski; J K deRiel; W E Mercer; B Calabretta; R Baserga
Journal:  Science       Date:  1988-06-10       Impact factor: 47.728

View more
  44 in total

1.  Proliferating cell nuclear antigen in oesophageal diseases; correlation with transforming growth factor alpha expression.

Authors:  J Jankowski; R McMenemin; C Yu; D Hopwood; K G Wormsley
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

2.  The role of the promoter in the expression of the PCNA gene.

Authors:  R H Charollais; H Alder; A Ferber; J Koniecki; C Sell; R Baserga
Journal:  Gene Expr       Date:  1992

3.  Identification and characterization of a noncoding RNA at the mouse Pcna locus.

Authors:  Ji-Yeon Lee; Abdul Aziz Khan; Hyehyun Min; Xinnan Wang; Myoung Hee Kim
Journal:  Mol Cells       Date:  2012-01-02       Impact factor: 5.034

4.  Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells.

Authors:  B E Pearson; H P Nasheuer; T S Wang
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

5.  Upstream sequences of rice proliferating cell nuclear antigen (PCNA) gene mediate expression of PCNA-GUS chimeric gene in meristems of transgenic tobacco plants.

Authors:  S Kosugi; I Suzuka; Y Ohashi; T Murakami; Y Arai
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

6.  Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.

Authors:  W E Mercer; M T Shields; D Lin; E Appella; S J Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

7.  E2F-dependent mitogenic stimulation of the splicing of transcripts from an S phase-regulated gene.

Authors:  M I Darville; G G Rousseau
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

8.  Tgfbr2 is required in osterix expressing cells for postnatal skeletal development.

Authors:  Sarah B Peters; Ying Wang; Rosa Serra
Journal:  Bone       Date:  2016-12-30       Impact factor: 4.398

9.  In vivo interpretation of in vitro effect studies with a detailed analysis of the method of in vitro transcription in isolated cell nuclei.

Authors:  R Strand; R Fjelland; T Flatmark
Journal:  Acta Biotheor       Date:  1996-03       Impact factor: 1.774

10.  Molecular analysis of p53 gene in laryngeal premalignant and malignant lesions. p53 protein immunohistochemical expression is positively related to proliferating cell nuclear antigen labelling index.

Authors:  V Gorgoulis; V Zoumpourlis; G Rassidakis; A Karameris; C Barbatis; D A Spandidos; C Kittas
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.